Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Sulfacetamide sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sulfacetamide sodium and what is the scope of sulfacetamide sodium freedom to operate?

Sulfacetamide sodium
is the generic ingredient in seventeen branded drugs marketed by Pharmafair, Fougera Pharms, Allergan, Akorn, Bausch And Lomb, Alcon, Optopics, Novartis, Perrigo Co Tennessee, Valeant Pharms North, Sola Barnes Hind, Miza Pharms Usa, Sandoz Inc, Schering, Taro, and Alcon Pharms Ltd, and is included in thirty NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for sulfacetamide sodium. Twenty-three suppliers are listed for this compound.

Summary for Generic Name: sulfacetamide sodium

Drug Master File Entries: see list3
Suppliers / Packagers: see list23
Bulk Api Vendors: see list136
Clinical Trials: see list924
Patent Applications: see list5,329
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:sulfacetamide sodium at DailyMed

Pharmacology for Ingredient: sulfacetamide sodium

Drug ClassSulfonamide Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo Co Tennessee
sulfacetamide sodium
OINTMENT;OPHTHALMIC080029-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe
sulfacetamide sodium
SOLUTION/DROPS;OPHTHALMIC083021-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
sulfacetamide sodium
OINTMENT;OPHTHALMIC084015-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
sulfacetamide sodium
SOLUTION/DROPS;OPHTHALMIC087949-001Dec 13, 1982DISCNNoNo► Subscribe► Subscribe
Perrigo Co Tennessee
sulfacetamide sodium
LOTION;TOPICAL078649-001Mar 23, 2009ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus